The store will not work correctly when cookies are disabled.
(E)-3-(4-(dimethylamino)phenyl)-1-(5-propylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288604
PubChem CID: 6474723
Max Phase: Preclinical
Molecular Formula: C18H21N3O
Molecular Weight: 295.39
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCc1cnc(C(=O)/C=C/c2ccc(N(C)C)cc2)cn1
Standard InChI: InChI=1S/C18H21N3O/c1-4-5-15-12-20-17(13-19-15)18(22)11-8-14-6-9-16(10-7-14)21(2)3/h6-13H,4-5H2,1-3H3/b11-8+
Standard InChI Key: RADPDBWPCSONNP-DHZHZOJOSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
35.7528 -15.4358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7516 -16.2553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4597 -16.6643 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1693 -16.2549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1665 -15.4322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4579 -15.0269 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.8727 -15.0209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5819 -15.4269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8696 -14.2038 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.2881 -15.0156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9973 -15.4215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9973 -16.2376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7057 -16.6434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4128 -16.2321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4071 -15.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6981 -15.0086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0436 -16.6634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0429 -17.4806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3349 -17.8886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1226 -16.6371 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.1268 -17.4543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8282 -16.2249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
2 17 1 0
17 18 1 0
18 19 1 0
14 20 1 0
20 21 1 0
20 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 295.39 | Molecular Weight (Monoisotopic): 295.1685 | AlogP: 3.39 | #Rotatable Bonds: 6 |
Polar Surface Area: 46.09 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.73 | CX LogP: 3.23 | CX LogD: 3.22 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.61 | Np Likeness Score: -0.71 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |